KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Dec 2024 value amounting to $226.5 million.

  • Acadia Pharmaceuticals' Consolidated Net Income rose 119.14% to $71.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $261.2 million, marking a year-over-year increase of 103.33%. This contributed to the annual value of $226.5 million for FY2024, which is 469.20% up from last year.
  • According to the latest figures from FY2024, Acadia Pharmaceuticals' Consolidated Net Income is $226.5 million, which was up 469.20% from -$61.3 million recorded in FY2023.
  • Acadia Pharmaceuticals' Consolidated Net Income's 5-year high stood at $226.5 million during FY2024, with a 5-year trough of -$281.6 million in FY2020.
  • In the last 3 years, Acadia Pharmaceuticals' Consolidated Net Income had a median value of -$61.3 million in 2023 and averaged -$17.0 million.
  • In the last 5 years, Acadia Pharmaceuticals' Consolidated Net Income declined by 28.66% in 2022 and then skyrocketed by 469.20% in 2024.
  • Yearly analysis of 5 years shows Acadia Pharmaceuticals' Consolidated Net Income stood at -$281.6 million in 2020, then surged by 40.38% to -$167.9 million in 2021, then declined by 28.66% to -$216.0 million in 2022, then skyrocketed by 71.60% to -$61.3 million in 2023, then soared by 469.20% to $226.5 million in 2024.